OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

AdTheorent Holding Company Inc

Cardiff Oncology

You get what you pay for and that includes stocks under $5. Yeah, I might be starting off on a negative foot but here's the deal: most securities that are priced this low are that way for a reason.

Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5

Aurora Cannabis

Neptune Wellness Solutions Inc.

More publicly traded cannabis companies are starting to report earnings. This alone has been another reason shareholders have seen a slight increase in trading momentum for marijuana stocks. Speculation is high in 2024 for those who are invested in legal cannabis. Political figures from all parties are starting to find common ground with the cannabis industry.

Top Marijuana Stocks For Trading Today 2024

As March 2024 begins, marijuana stocks are catching the eyes of investors looking for potential growth opportunities. The cannabis industry in the U.S. has seen rapid expansion and evolution, driven by increasing legalization and public acceptance. Several marijuana companies, operating at lower stock prices, offer intriguing entry points for speculative investment. These companies range from growers and retailers to technology firms offering innovative cultivation, distribution, and consumer experience solutions. With the dynamic landscape of the cannabis sector, these penny stocks represent both the volatility and potential rewards that come with early-stage investment in a growing industry.

2 Top Marijuana Penny Stocks with High Momentum Before March 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) enthusiastically supports the Standing Committee on Finance's recent recommendation on the Excise Duty framework. In a recently released report, titled ‘Shaping our Economic Future: Canadian Priorities,' the House of Commons Standing Committee on Finance has unanimously recommended adjusting the excise duty formula for cannabis so that it is limited to a 10% ad valorem rate, and modifyin.

Organigram Applauds the Standing Committee on Finance's Recommendation on Excise Duty

Canopy Growth

Cannabis firms OrganiGram Holdings (TSX-V:OGI, NASDAQ:OGI) and Aurora Cannabis Inc (TSX:ACB, NASDAQ:ACB) are increasingly attractive on the back of encouraging quarterly financial results, analysts at Jefferies believe.  They have a ‘Buy' rating on Organigram, which they said remains a top Canadian cannabis pick, writing in a note to clients that Organigram's first quarter 2024 earnings showed progress on every metric.

Organigram and Aurora Cannabis increasingly attractive as Canopy Growth's core operations struggle: analysts

Cronos Group

SNDL Inc.

Support for the legalization of cannabis is at an all-time high. In fact, according to a recent Gallup poll, about 70% of all Americans support legalization.

3 Millionaire-Maker Cannabis Penny Stocks to Buy in February 2024

Organigram Holdings Inc. (OGI) Q1 2024 Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2023 (“Q1 Fiscal 2024”). “We certainly kicked off fiscal 2024 with a bang", said Beena Goldenberg, Chief Executive Officer. “By closing the first tranche of our $124.6 million follow-on investment from BAT shortly after quarter end, we have removed a significant amount of risk from ou.

Organigram Reports First Quarter Fiscal 2024 Results

In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Market movements were influenced by quarterly earnings reports, with some companies exceeding expectations and others falling short. This period saw significant attention to operational efficiencies and international expansion efforts. Additionally, updates on product innovation and strategic partnerships were crucial. Investors closely monitored these developments, leveraging technical analysis to identify potential entry and exit points.

Leading Canadian Cannabis Stock Powers Through with Strong Weekly Momentum

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 13, 2024 Time: 8:00 am Easte.

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis today announced that it has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, a health and sciences organization dedicated to the medical applications of cannabinoids. Organigram is pleased to complete its first shipment to Germany, one of the world's largest and growing medical markets,.

Organigram Completes First Shipment to Germany, Extending its International Reach

GrowGeneration Corp

Tilray Brands

Given recent news items regarding the federal legalization of cannabis, you may think now is the time to be thinking about which cannabis stocks to buy, not which cannabis stocks to sell. Yes, the release of a letter from the U.S. Department of Health and Human Services, recommending that marijuana be rescheduled as a Schedule III drug, may be seen as signs of marijuana legalization progress.

7 Cannabis Stocks to Sell as the Industry Faces Legal Uncertainty in 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the first tranche closing, the Investor acquired 12,893,175 com.

Organigram Announces the First Tranche Closing from BAT Investment

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company's annual general and special meeting held on January 18, 2024. “We are thrilled to welcome Karina to our Board of Directors. Her extensive expertise in marketing and brand management combined with her ongoing experience with BAT will be a tremendous asset to our Board,” said Peter Amirault, Bo.

Organigram Announces Appointment of Karina Gehring to Board of Directors

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on January 18, 2024 (the “Meeting”). Election of Directors Each of the nine nominees listed in the Company's management information circular dated December 20, 2023 (the “Circular”) provided in connection with the Meeting were elected as directors of the Comp.

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

Organigram's Q4 results exceeded revenue expectations but had weaker than expected adjusted EBITDA. Analysts have lowered their projections for Organigram's revenue and adjusted EBITDA for FY24 and FY25. British American Tobacco (BAT) is buying a larger stake in Organigram at a significant premium, but not acquiring the entire company.

Why Organigram Is My Favorite Cannabis Stock

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on January 18, 2024. In addition to routine annual business to be conducted (includin.

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Organigram Holdings Inc. (OGI) Q4 2023 Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter and thirteen months ended September 30, 2023 (“Q4 Fiscal 2023” or "Fiscal 2023"). "In Fiscal 2023, our continued focus on innovative products that address consumers' evolving preferences toward convenience drove our growth across several ready-to-consume categories like pre-rolls and edibles, and we en.

Organigram Reports Fiscal 2023 Results1

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024. Mr. Guyatt will lead Organigram's Finance and IT divisions and will report directly to Beena Goldenberg, Organigram's Chief Executive Officer. Mr. Guyatt is a seasoned financial executive with over 25 years of in.

Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer

Innovative Industrial Properties

In the bustling stock markets, the cannabis industry has emerged as a dynamic arena, captivating investors with its promise of rapid evolution and immense growth potential. As the smoke clears from regulatory shifts and market fluctuations, the spotlight shines on three trailblazing cannabis stocks poised for substantial strides in 2024.

Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ended September 30, 2023, on Tuesday, December 19, 2023, before market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 19, 2023 Time: 8:00 am E.

Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Leafly Holdings

Valley National

As 2024 looms on the horizon, the cannabis sector stands at the cusp of an exciting era. This likely surge is fueled by a blend of political backing and a shift in public opinion.

Rescheduling & Legalization: 7 Cannabis Stocks Set to Surge in 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is thrilled to announce it has won KIND Magazine's (“KIND”) Innovation of the Year award for its revolutionary SHRED X Rip-Strips Hash. This is the second time Organigram has won this coveted award, having previously won for the Company's patented Edison JOLTS ingestible extract product. “We are very proud to be recognized by.

Organigram Wins KIND Magazine's Innovation of the Year for SHRED X Rip-Strips Hash

Are marijuana stock investors using volatility to their advantage? As most know the cannabis sector is a place where most of the pot stocks trade with inconsistent patterns. Now to elaborate most companies trade with patterns that often show major volatility. This is what makes it tough to identify when it is time to buy or sell. To be more descriptive when there is a jump in trading you do not know how long it will last.

News for OrganiGram Holdings Inc. Stock (OGI)